← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

PDEX logoPro-Dex, Inc.(PDEX)Earnings, Financials & Key Ratios

PDEX•NASDAQ
$57.42
$184M mkt cap·21.5× P/E·Price updated May 7, 2026
SectorHealthcareIndustryMedical InstrumentsSub-IndustrySurgical and interventional devices
AboutPro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.Show more
  • Revenue$67M+23.7%
  • EBITDA$12M+43.1%
  • Net Income$9M+322.1%
  • EPS (Diluted)2.67+345.0%
  • Gross Margin29.3%+8.4%
  • EBITDA Margin17.91%+15.7%
  • Operating Margin16.05%+20.5%
  • Net Margin13.48%+241.3%
  • ROE26.6%+290.6%
  • ROIC16.95%+34.3%
  • Debt/Equity0.45+3.1%
  • Interest Coverage15.55+171.7%
Technical→

PDEX Key Insights

Pro-Dex, Inc. (PDEX) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 13.8%
  • ✓Good 3Y average ROE of 19.4%
  • ✓Share count reduced 5.9% through buybacks
  • ✓Healthy 5Y average net margin of 10.9%
  • ✓Trading near 52-week high
  • ✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

  • ✗Negative free cash flow

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

PDEX Price & Volume

Pro-Dex, Inc. (PDEX) stock price & volume — 10-year historical chart

Loading chart...

PDEX Growth Metrics

Pro-Dex, Inc. (PDEX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years17.41%
5 Years13.84%
3 Years16.57%
TTM16.39%

Profit CAGR

10 Years-
5 Years7.99%
3 Years25.23%
TTM28.11%

EPS CAGR

10 Years-
5 Years12.22%
3 Years30.19%
TTM29.29%

Return on Capital

10 Years18.75%
5 Years17.29%
3 Years18.93%
Last Year24.82%

PDEX Recent Earnings

Pro-Dex, Inc. (PDEX) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 30, 2026
EPS
$1.20
Est $0.62
+93.5%
Revenue
$20M
Est $18M
+11.4%
Q1 2026
Jan 29, 2026
EPS
$0.66
Est $0.59
+11.9%
Revenue
$19M
Est $17M
+7.9%
Q4 2025
Oct 30, 2025
EPS
$0.62
Est $0.50
+24.0%
Revenue
$19M
Est $15M
+21.1%
Q4 2025
Sep 4, 2025
EPS
$0.36
Est $0.47
-23.4%
Revenue
$17M
Est $15M
+14.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 30, 2026
$1.20vs $0.62+93.5%
$20Mvs $18M+11.4%
Q1 2026Jan 29, 2026
$0.66vs $0.59+11.9%
$19Mvs $17M+7.9%
Q4 2025Oct 30, 2025
$0.62vs $0.50+24.0%
$19Mvs $15M+21.1%
Q4 2025Sep 4, 2025
$0.36vs $0.47-23.4%
$17Mvs $15M+14.3%
Based on last 12 quarters of dataView full earnings history →

PDEX Peer Comparison

Pro-Dex, Inc. (PDEX) competitors in Surgical and interventional devices — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
NSYS logoNSYSNortech Systems IncorporatedDirect Competitor34.88M12.52-26.64-8.04%-2.25%-7.88%0.53
LIQT logoLIQTLiqTech International, Inc.Direct Competitor22.21M2.31-2.5913.03%-53.25%-69.97%1.17
ATRC logoATRCAtriCure, Inc.Product Competitor1.41B27.80-115.8314.88%-0.83%-0.95%0.18
MMSI logoMMSIMerit Medical Systems, Inc.Product Competitor3.72B62.3329.2611.66%9.03%8.95%0.57
NVCR logoNVCRNovoCure LimitedProduct Competitor1.92B16.83-13.808.28%-25.66%-50.82%0.85
OSIS logoOSISOSI Systems, Inc.Product Competitor3.97B241.1127.6811.33%8.42%16.74%0.72
SYK logoSYKStryker CorporationSupply Chain112.69B294.2535.0311.16%12.92%15.04%0.66
ZBH logoZBHZimmer Biomet Holdings, Inc.Supply Chain16.32B83.3723.487.2%9.05%5.77%0.59

Compare PDEX vs Peers

Pro-Dex, Inc. (PDEX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NSYS

Most directly comparable listed peer for PDEX.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare PDEX against a more recognizable public peer.

Peer Set

Compare Top 5

vs NSYS, LIQT, ATRC, MMSI

PDEX Income Statement

Pro-Dex, Inc. (PDEX) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Sales/Revenue21.94M22.46M27.17M34.83M42.04M42.04M46.09M53.84M66.59M74.64M
Revenue Growth %8.86%2.38%20.95%28.2%20.69%0%9.62%16.83%23.68%16.39%
Cost of Goods Sold14.76M14.52M17.39M21.69M28.91M28.91M33.34M39.29M47.08M53.9M
COGS % of Revenue67.25%64.64%64.01%62.27%68.76%68.76%72.34%72.98%70.7%-
Gross Profit
7.19M▲ 0%
7.94M▲ 10.5%
9.78M▲ 23.1%
13.14M▲ 34.4%
13.13M▼ 0.1%
13.13M▲ 0.0%
12.75M▼ 2.9%
14.55M▲ 14.1%
19.51M▲ 34.1%
20.73M▲ 0%
Gross Margin %32.75%35.36%35.99%37.73%31.24%31.24%27.66%27.02%29.3%27.78%
Gross Profit Growth %33%10.53%23.13%34.38%-0.08%0%-2.92%14.13%34.08%-
Operating Expenses4.34M4.54M4.79M6.08M8.01M8.01M6.99M7.38M8.82M9.93M
OpEx % of Revenue19.77%20.2%17.62%17.46%19.05%19.05%15.16%13.7%13.25%-
Selling, General & Admin3.11M2.65M2.91M3.77M4.99M4.99M4.18M4.19M5.18M6.69M
SG&A % of Revenue14.19%11.77%10.7%10.81%11.88%11.88%9.08%7.78%7.79%-
Research & Development1.23M1.89M1.88M2.31M2.98M2.98M2.8M3.19M3.64M3.23M
R&D % of Revenue5.58%8.43%6.93%6.65%7.09%7.09%6.08%5.92%5.46%-
Other Operating Expenses0045K035K35K0000
Operating Income
2.73M▲ 0%
2.39M▼ 12.5%
5M▲ 108.9%
7.07M▲ 41.4%
5.12M▼ 27.5%
5.12M▲ 0.0%
5.76M▲ 12.5%
7.17M▲ 24.5%
10.69M▲ 49.0%
10.81M▲ 0%
Operating Margin %12.46%10.65%18.39%20.28%12.19%12.19%12.5%13.32%16.05%14.48%
Operating Income Growth %419.77%-12.51%108.95%41.38%-27.5%0%12.47%24.49%49.02%-
EBITDA3.29M2.95M5.44M7.68M5.85M5.85M6.62M8.33M11.93M12.72M
EBITDA Margin %14.99%13.13%20.01%22.05%13.91%13.91%14.36%15.48%17.91%17.05%
EBITDA Growth %191.32%-10.34%84.33%41.28%-23.84%0%13.16%25.9%43.14%6.48%
D&A (Non-Cash Add-back)555K557K438K614K726K726K857K1.16M1.24M1.92M
EBIT2.85M3.4M4.99M8.14M6.16M6.16M9.96M3.19M12.89M11.81M
Net Interest Income15K218K48K-141K-226K-388K-239K-414K-747K-473K
Interest Income27K225K268K95K126K76K294K144K82K95K
Interest Expense12K7K220K236K352K464K533K558K829K367K
Other Income/Expense15K218K449K836K571K571K3.67M-4.54M1.37M5.28M
Pretax Income
2.75M▲ 0%
2.61M▼ 5.2%
5.45M▲ 108.7%
7.9M▲ 45.1%
5.69M▼ 27.9%
5.69M▲ 0.0%
9.43M▲ 65.6%
2.63M▼ 72.1%
12.06M▲ 357.8%
16.09M▲ 0%
Pretax Margin %12.54%11.62%20.05%22.68%13.54%13.54%20.46%4.89%18.11%21.56%
Income Tax-2.09M989K1.3M1.79M1.12M1.12M2.35M507K3.08M4.09M
Effective Tax Rate %-75.91%37.89%23.85%22.65%19.7%19.7%24.97%19.25%25.54%25.41%
Net Income
5.08M▲ 0%
1.62M▼ 68.1%
4.15M▲ 155.9%
6.11M▲ 47.3%
4.57M▼ 25.2%
4.57M▲ 0.0%
7.07M▲ 54.7%
2.13M▼ 69.9%
8.98M▲ 322.1%
12M▲ 0%
Net Margin %23.17%7.22%15.27%17.55%10.88%10.88%15.35%3.95%13.48%16.08%
Net Income Growth %518.49%-68.12%155.89%47.35%-25.2%0%54.72%-69.93%322.1%28.11%
Net Income (Continuing)4.84M1.62M4.15M6.11M4.57M4.57M7.07M2.13M8.98M12M
Discontinued Operations243K000000000
Minority Interest0000000000
EPS (Diluted)
1.25▲ 0%
0.37▼ 70.4%
0.97▲ 162.2%
1.50▲ 54.6%
1.13▼ 24.7%
1.21▲ 7.1%
1.95▲ 61.2%
0.60▼ 69.2%
2.67▲ 345.0%
3.67▲ 0%
EPS Growth %525%-70.4%162.16%54.64%-24.67%7.08%61.16%-69.23%345%29.29%
EPS (Basic)1.260.380.991.561.171.261.980.612.73-
Diluted Shares Outstanding4.08M4.34M4.3M4.08M3.94M3.76M3.64M3.57M3.36M3.27M
Basic Shares Outstanding4.04M4.3M4.19M3.91M3.8M3.64M3.57M3.5M3.29M3.2M
Dividend Payout Ratio--0.55%-------

PDEX Balance Sheet

Pro-Dex, Inc. (PDEX) balance sheet — assets, liabilities & shareholders' equity

Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Total Current Assets11.92M16.23M21.78M22.67M31.17M31.17M30.98M36.61M47.3M53.71M
Cash & Short-Term Investments4.92M7.41M10.39M8.98M1.6M1.6M4.07M6.85M7.16M9.99M
Cash Only4.21M5.19M7.74M6.42M849K849K2.94M2.63M419K9.99M
Short-Term Investments718K2.22M2.65M2.56M755K755K1.13M4.22M6.74M0
Accounts Receivable3.62M4.13M4.1M5.16M15.38M15.38M9.95M13.89M17.49M19.47M
Days Sales Outstanding60.2867.1255.0854.02133.56133.5678.8294.1495.8689.8
Inventory3.08M4.39M6.24M8.24M12.68M12.68M16.17M15.27M22.21M22.36M
Days Inventory Outstanding76.3110.41130.94138.62160.07160.07177141.84172.2148.71
Other Current Assets374K32K430K155K710K710K494K262K434K1.89M
Total Non-Current Assets4.43M3.68M3.74M8.45M17.92M17.92M20.84M15.87M13.9M21.27M
Property, Plant & Equipment1.43M1.75M2.73M5.63M13.42M13.42M13.2M12.65M1.05M716K
Fixed Asset Turnover15.36x12.80x9.97x6.19x3.13x3.13x3.49x4.26x63.42x20.53x
Goodwill112K000000006.53M
Intangible Assets320K140K129K162K118K118K81K54K26K712K
Long-Term Investments450K43K582K2.36M4.08M4.08M7.52M1.56M148K888K
Other Non-Current Assets71K68K40K42K42K42K42K42K11.26M33.7M
Total Assets
16.35M▲ 0%
19.92M▲ 21.8%
25.52M▲ 28.1%
31.13M▲ 22.0%
49.09M▲ 57.7%
49.09M▲ 0.0%
51.82M▲ 5.6%
52.48M▲ 1.3%
61.19M▲ 16.6%
74.98M▲ 0%
Asset Turnover1.34x1.13x1.06x1.12x0.86x0.86x0.89x1.03x1.09x1.14x
Asset Growth %46.69%21.81%28.13%21.97%57.71%0%5.57%1.26%16.61%51.05%
Total Current Liabilities2.58M2.54M4.27M5.23M11.35M11.35M9.68M12.89M14.63M14.64M
Accounts Payable1.16M1.08M2M1.97M3.76M3.76M2.26M4.51M4.61M5.25M
Days Payables Outstanding28.6727.2241.8933.0647.4947.4924.7541.9235.7730.36
Short-Term Debt26K35K622K651K3.29M3.29M3.83M4.37M6.15M4.19M
Deferred Revenue (Current)19K31K215K200K1.01M1.01M014K202K631K
Other Current Liabilities528K807K0000001.63M5.05M
Current Ratio4.62x6.40x5.10x4.34x2.74x2.74x3.20x2.84x3.23x3.23x
Quick Ratio3.42x4.67x3.64x2.76x1.63x1.63x1.53x1.66x1.71x1.71x
Cash Conversion Cycle107.92150.31144.12159.57246.15246.15231.07194.05232.29208.15
Total Non-Current Liabilities61K103K4.24M6.84M12.3M12.3M10.56M8.72M9.93M15.14M
Long-Term Debt06K3.93M3.28M10.25M10.25M8.91M7.54M9.25M15.14M
Capital Lease Obligations61K6K02.75M2.05M2.05M1.64M1.18M685K1.66M
Deferred Tax Liabilities758K476K614K0008K000
Other Non-Current Liabilities091K308K804K00000-419K
Total Liabilities2.64M2.64M8.51M12.06M23.66M23.66M20.23M21.61M24.56M29.78M
Total Debt119K41K4.56M7.02M15.97M15.97M14.79M13.55M16.58M19.33M
Net Debt-4.09M-5.15M-3.19M602K15.12M15.12M11.86M10.92M16.16M9.34M
Debt / Equity0.01x0.00x0.27x0.37x0.63x0.63x0.47x0.44x0.45x0.45x
Debt / EBITDA0.04x0.01x0.84x0.91x2.73x2.73x2.23x1.63x1.39x1.52x
Net Debt / EBITDA-1.24x-1.75x-0.59x0.08x2.58x2.58x1.79x1.31x1.35x1.35x
Interest Coverage237.25x486.43x22.69x34.48x17.49x13.27x18.69x5.72x15.55x32.18x
Total Equity
13.71M▲ 0%
17.28M▲ 26.0%
17.01M▼ 1.6%
19.06M▲ 12.1%
25.43M▲ 33.4%
25.43M▲ 0.0%
31.59M▲ 24.2%
30.87M▼ 2.3%
36.63M▲ 18.7%
45.2M▲ 0%
Equity Growth %54.44%26.01%-1.55%12.08%33.41%0%24.22%-2.29%18.68%112.05%
Book Value per Share3.363.983.964.676.466.768.698.6410.9013.82
Total Shareholders' Equity13.71M17.28M17.01M19.06M25.43M25.43M31.59M30.87M36.63M45.2M
Common Stock17.7M19.84M15.81M12.75M7.68M7.68M6.77M3.92M704K0
Retained Earnings-4.03M-2.41M1.74M7.9M17.75M17.75M24.82M26.95M35.93M45.2M
Treasury Stock0000000000
Accumulated OCI33K-153K-549K-1.59M000000
Minority Interest0000000000

PDEX Cash Flow Statement

Pro-Dex, Inc. (PDEX) cash flow — operating, investing & free cash flow history

Line itemJun'17Jun'18Jun'19Jun'20Jun'21Jun'22Jun'23Jun'24Jun'25TTM
Cash from Operations3.23M3.1M3.33M5.9M-847K-847K5.46M6.2M-1.68M-1.68M
Operating CF Margin %14.74%13.78%12.24%16.93%-2.01%-2.01%11.85%11.51%-2.53%-
Operating CF Growth %594.21%-4.3%7.43%77.3%-114.36%0%744.86%13.49%-127.13%208.11%
Net Income5.08M1.62M4.15M6.11M4.57M4.57M7.07M2.13M8.98M12M
Depreciation & Amortization555K557K438K573K726K726K857K1.16M1.24M1.3M
Stock-Based Compensation3K194K37K286K1.27M1.27M766K605K555K665K
Deferred Taxes-2.05M391K1.42M-22K-63K-63K264K-1.56M140K138K
Other Non-Cash Items-234K1.03M-370K26K-820K-820K-3.9M4.09M-2.14M-6.09M
Working Capital Changes-125K-694K-2.35M-1.08M-6.54M-6.54M396K-225K-10.45M-670K
Change in Receivables-633K569K-1.13M-1.06M-4.45M-4.45M5.43M-3.94M-2.55M-2.81M
Change in Inventory279K-1.31M-1.85M-2M-4.24M-4.24M-3.49M898K-6.94M1.95M
Change in Payables518K-57K1.13M604K1.99M1.99M-1.15M2.44M179K-486K
Cash from Investing-1.03M-4.12M-1.22M-3.24M-1.24M-1.24M-885K-2.23M-238K2.72M
Capital Expenditures-638K-934K-1.4M-565K-1.64M-1.64M-974K-983K-1.25M-93K
CapEx % of Revenue2.91%4.16%5.15%1.62%3.9%3.9%2.11%1.83%1.87%-
Acquisitions636K30K19K-978K000000
Investments----------
Other Investing-447K-320K1.23M998K-33K-33K00-304K-6.78M
Cash from Financing-298K2M450K-3.98M-790K-790K-2.49M-4.27M-292K-11.23M
Debt Issued (Net)-59K-78K4.51M-630K8.79M756K-809K-816K3.48M-8.41M
Equity Issued (Net)-312K2.04M-4.08M-3.39M-5.44M-1.61M-1.55M-3.5M-3.46M-2.79M
Dividends Paid00-23K0000000
Share Repurchases-312K-220K-3.98M-3.39M-5.54M-1.61M-1.55M-3.5M-3.5M-2.88M
Other Financing73K38K51K39K-4.14M60K-134K50K-305K-27K
Net Change in Cash
1.91M▲ 0%
983K▼ 48.6%
2.55M▲ 159.8%
-1.32M▼ 151.7%
-2.87M▼ 117.4%
-2.87M▲ 0.0%
2.09M▲ 172.7%
-305K▼ 114.6%
-2.21M▼ 625.2%
-1.16M▲ 0%
Free Cash Flow
2.6M▲ 0%
2.16M▼ 16.8%
1.93M▼ 10.8%
5.33M▲ 176.6%
-2.52M▼ 147.2%
-2.52M▲ 0.0%
4.49M▲ 278.2%
5.22M▲ 16.2%
-2.93M▼ 156.1%
7.07M▲ 0%
FCF Margin %11.84%9.62%7.1%15.31%-5.99%-5.99%9.74%9.69%-4.4%9.47%
FCF Growth %1882.44%-16.75%-10.82%176.56%-147.22%0%278.24%16.22%-156.13%504.06%
FCF per Share0.640.500.451.31-0.64-0.671.231.46-0.87-0.87
FCF Conversion (FCF/Net Income)0.64x1.91x0.80x0.96x-0.19x-0.19x0.77x2.91x-0.19x0.59x
Interest Paid12K7K199K218K463K463K521K555K818K608K
Taxes Paid217K401K320K683K1.56M1.56M1.66M1.89M4.46M1.11M

PDEX Key Ratios

Pro-Dex, Inc. (PDEX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric201720182019202020212022202320242025TTM
Return on Equity (ROE)45.02%10.46%24.2%33.89%20.55%17.98%24.81%6.81%26.6%29.1%
Return on Invested Capital (ROIC)25.19%16.49%28.89%31.65%12.76%9.48%10.29%12.62%16.95%16.95%
Gross Margin32.75%35.36%35.99%37.73%31.24%31.24%27.66%27.02%29.3%27.78%
Net Margin23.17%7.22%15.27%17.55%10.88%10.88%15.35%3.95%13.48%16.08%
Debt / Equity0.01x0.00x0.27x0.37x0.63x0.63x0.47x0.44x0.45x0.45x
Interest Coverage237.25x486.43x22.69x34.48x17.49x13.27x18.69x5.72x15.55x32.18x
FCF Conversion0.64x1.91x0.80x0.96x-0.19x-0.19x0.77x2.91x-0.19x0.59x
Revenue Growth8.86%2.38%20.95%28.2%20.69%0%9.62%16.83%23.68%16.39%

PDEX SEC Filings & Documents

Pro-Dex, Inc. (PDEX) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 30, 2026·SEC

Material company update

Mar 27, 2026·SEC

Material company update

Feb 12, 2026·SEC

10-K Annual Reports

3
FY 2025

Sep 4, 2025·SEC

FY 2024

Sep 5, 2024·SEC

FY 2023

Oct 13, 2023·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 30, 2026·SEC

FY 2026

Jan 29, 2026·SEC

FY 2025

Oct 30, 2025·SEC

PDEX Frequently Asked Questions

Pro-Dex, Inc. (PDEX) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Pro-Dex, Inc. (PDEX) reported $74.6M in revenue for fiscal year 2025. This represents a 259% increase from $20.8M in 1996.

Pro-Dex, Inc. (PDEX) grew revenue by 23.7% over the past year. This is strong growth.

Yes, Pro-Dex, Inc. (PDEX) is profitable, generating $12.0M in net income for fiscal year 2025 (13.5% net margin).

Dividend & Returns

Pro-Dex, Inc. (PDEX) has a return on equity (ROE) of 26.6%. This is excellent, indicating efficient use of shareholder capital.

Pro-Dex, Inc. (PDEX) generated $7.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More PDEX

Pro-Dex, Inc. (PDEX) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.